Trial Profile
A Phase 1b Randomized Double-Blind Clinical Trial to Examine Whether Polytopic Administration of VRC rAd5 Gag-pol/Env A/B/C Vaccine Enhances HIV-Specific Cellular Immune Responses in Humans.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs VRC HIVADV052 00 VP (Primary) ; VRC HIVADV054 00 VP (Primary) ; VRC-HIVADV014-00-VP (Primary) ; VRC-HIVADV038-00-VP (Primary) ; VRC-HIVADV053-00-VP (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 29 May 2018 Status changed from active, no longer recruiting to completed.
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.